82.1 F
San Fernando
Wednesday, Apr 2, 2025

Amgen Off 4% Friday

The Thousand Oaks drug maker Amgen Inc. finished Friday down more than 4 percent and hit a year-low after a week of rough news. The biotech firm Friday announced it was canceling its clinical trials on Vectibix after tests showed using the drug with another medical might exacerbates the health of some cancer patients. Vectibix is the first direct cancer drug developed my Amgen. The study looked at the drug in combination with chemotherapy and Avastin, a drug developed by Genetech. The company has also been dealing with safety concerns about its popular anemia drug, Aranesp. Earlier this week, a congressional committee leader asked the company to stop advertising its effectiveness.

Featured Articles

Related Articles

' + // image style settings '
' + 'tagDiv image style' + '' + '
' + ''; //inject our settings in the template - before
td_template_content = td_template_content.replace('
', td_our_content + '
'); //save the template jQuery('#tmpl-image-details').html(td_template_content); //modal off - click event jQuery(document).on( "click", ".td-modal-image-on", function() { if (jQuery(this).hasClass('active')) { return; } td_add_image_css_class('td-modal-image'); jQuery(".td-modal-image-off").removeClass('active'); jQuery(".td-modal-image-on").addClass('active'); }); //modal on - click event jQuery(document).on( "click", ".td-modal-image-off", function() { if (jQuery(this).hasClass('active')) { return; } td_remove_image_css_class('td-modal-image'); jQuery(".td-modal-image-off").addClass('active'); jQuery(".td-modal-image-on").removeClass('active'); }); // select change event jQuery(document).on( "change", ".td-wp-image-style", function() { switch (jQuery( ".td-wp-image-style").val()) { default: td_clear_all_classes(); //except the modal one jQuery('*[data-setting="extraClasses"]').change(); //trigger the change event for backbonejs } }); //util functions to edit the image details in wp-admin function td_add_image_css_class(new_class) { var td_extra_classes_value = jQuery('*[data-setting="extraClasses"]').val(); jQuery('*[data-setting="extraClasses"]').val(td_extra_classes_value + ' ' + new_class); jQuery('*[data-setting="extraClasses"]').change(); //trigger the change event for backbonejs } function td_remove_image_css_class(new_class) { var td_extra_classes_value = jQuery('*[data-setting="extraClasses"]').val(); //try first with a space before the class var td_regex = new RegExp(" " + new_class,"g"); td_extra_classes_value = td_extra_classes_value.replace(td_regex, ''); var td_regex = new RegExp(new_class,"g"); td_extra_classes_value = td_extra_classes_value.replace(td_regex, ''); jQuery('*[data-setting="extraClasses"]').val(td_extra_classes_value); jQuery('*[data-setting="extraClasses"]').change(); //trigger the change event for backbonejs } //clears all classes except the modal image one function td_clear_all_classes() { var td_extra_classes_value = jQuery('*[data-setting="extraClasses"]').val(); if (td_extra_classes_value.indexOf('td-modal-image') > -1) { //we have the modal image one - keep it, remove the others jQuery('*[data-setting="extraClasses"]').val('td-modal-image'); } else { jQuery('*[data-setting="extraClasses"]').val(''); } } //monitor the backbone template for the current status of the picture setInterval(function(){ var td_extra_classes_value = jQuery('*[data-setting="extraClasses"]').val(); if (typeof td_extra_classes_value !== 'undefined' && td_extra_classes_value != '') { // if we have modal on, switch the toggle if (td_extra_classes_value.indexOf('td-modal-image') > -1) { jQuery(".td-modal-image-off").removeClass('active'); jQuery(".td-modal-image-on").addClass('active'); } } }, 1000); })(); //end anon function -->